Total Payments
$81,053
2024 Payments
$1,350
Companies
48
Transactions
412
Medicare Patients
7,045
Medicare Billing
$931,243
Payment Breakdown by Category
Consulting$58,386 (72.0%)
Food & Beverage$9,699 (12.0%)
Other$6,950 (8.6%)
Travel$6,017 (7.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $58,386 | 47 | 72.0% |
| Food and Beverage | $9,699 | 343 | 12.0% |
| Travel and Lodging | $6,017 | 19 | 7.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,950 | 2 | 4.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,000 | 1 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Endologix LLC | $56,146 | 93 | $0 (2024) |
| Bard Peripheral Vascular, Inc. | $6,533 | 8 | $0 (2023) |
| Cardiovascular Systems Inc. | $6,415 | 27 | $0 (2023) |
| Medtronic Vascular, Inc. | $5,601 | 34 | $0 (2020) |
| W. L. Gore & Associates, Inc. | $1,548 | 12 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $511.92 | 37 | $0 (2024) |
| Boston Scientific Corporation | $388.15 | 15 | $0 (2023) |
| Edwards Lifesciences Corporation | $387.92 | 7 | $0 (2024) |
| Philips Electronics North America Corporation | $340.25 | 20 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $242.04 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,350 | 21 | Endologix LLC ($934.30) |
| 2023 | $1,423 | 49 | Endologix LLC ($610.78) |
| 2022 | $8,052 | 52 | Endologix LLC ($5,859) |
| 2021 | $9,809 | 18 | Endologix LLC ($9,652) |
| 2020 | $8,681 | 20 | Endologix, LLC ($8,280) |
| 2019 | $14,688 | 51 | Endologix, Inc. ($11,870) |
| 2018 | $22,482 | 104 | Endologix, Inc. ($13,972) |
| 2017 | $14,567 | 97 | Bard Peripheral Vascular, Inc. ($6,336) |
All Payment Transactions
412 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Genetic Disease | ||||||
| 11/19/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Not Applicable | ||||||
| 11/07/2024 | Endologix LLC | Alto Abdominal Stent Graft System (Device) | Food and Beverage | In-kind items and services | $317.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Penumbra, Inc. | Penumbra System (Device) | Food and Beverage | Cash or cash equivalent | $13.08 | General |
| Category: Neurointervention | ||||||
| 10/28/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $31.59 | General |
| Category: EndoVenous Therapies | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/06/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $69.09 | General |
| Category: VTE | ||||||
| 10/02/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $53.80 | General |
| Category: EndoVenous Therapies | ||||||
| 09/25/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.69 | General |
| Category: Cardiovascular | ||||||
| 09/19/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $30.13 | General |
| Category: Transcatheter Heart Valves | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: DIABETES | ||||||
| 07/09/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.58 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/03/2024 | Endologix LLC | Alto Abdominal Stent Graft System (Device) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/11/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/10/2024 | Endologix LLC | Alto Abdominal Stent Graft System (Device) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/15/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.29 | General |
| 02/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/31/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Cardiology | ||||||
| 11/27/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Cardiology | ||||||
| 10/31/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/16/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.71 | General |
| Category: Cardiovascular | ||||||
| 10/04/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,637 | 2,126 | $521,205 | $203,992 |
| 2022 | 30 | 1,847 | 2,504 | $633,956 | $247,285 |
| 2021 | 33 | 1,704 | 2,366 | $592,738 | $234,164 |
| 2020 | 36 | 1,857 | 2,592 | $619,125 | $245,802 |
Total Patients
7,045
Total Services
9,588
Medicare Billing
$931,243
Procedure Codes
134
All Medicare Procedures & Services
134 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 30 | 30 | $90,000 | $54,208 | 60.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 180 | 245 | $39,200 | $19,443 | 49.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 141 | 146 | $56,940 | $19,244 | 33.8% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 29 | 58 | $44,660 | $13,413 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 199 | 240 | $25,200 | $13,186 | 52.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 34 | 34 | $44,710 | $10,640 | 23.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 57 | 232 | $19,720 | $9,906 | 50.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 99 | 130 | $14,300 | $7,775 | 54.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 50 | 53 | $16,430 | $6,953 | 42.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 43 | 74 | $11,840 | $6,642 | 56.1% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 35 | 70 | $13,650 | $5,844 | 42.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 110 | 113 | $11,865 | $5,780 | 48.7% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 28 | 38 | $10,830 | $5,111 | 47.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 19 | 19 | $45,220 | $3,895 | 8.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 284 | 334 | $21,710 | $3,090 | 14.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 66 | 69 | $17,250 | $2,976 | 17.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 30 | $6,300 | $2,945 | 46.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $6,615 | $2,801 | 42.3% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 11 | 13 | $4,290 | $2,084 | 48.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 15 | 16 | $4,800 | $2,052 | 42.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $3,680 | $1,835 | 49.9% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 12 | 16 | $3,040 | $1,384 | 45.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 18 | 18 | $2,070 | $1,106 | 53.4% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 26 | 27 | $1,350 | $521.10 | 38.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 15 | 15 | $1,575 | $439.35 | 27.9% |
About Dr. Jacob Townsend, MD
Dr. Jacob Townsend, MD is a Cardiovascular Disease healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1003932955.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jacob Townsend, MD has received a total of $81,053 in payments from pharmaceutical and medical device companies, with $1,350 received in 2024. These payments were reported across 412 transactions from 48 companies. The most common payment nature is "Consulting Fee" ($58,386).
As a Medicare-enrolled provider, Townsend has provided services to 7,045 Medicare beneficiaries, totaling 9,588 services with total Medicare billing of $931,243. Data is available for 4 years (2020–2023), covering 134 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease, Interventional Cardiology
- Location Birmingham, AL
- Active Since 03/22/2007
- Last Updated 02/24/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1003932955
Products in Payments
- AFX (Device) $30,425
- Alto Abdominal Stent Graft System (Device) $14,052
- Ovation (Device) $8,470
- Peripheral Orbital Atherectomy System (Device) $6,359
- BPV-Lutonix (Device) $6,336
- HawkOne (Device) $4,635
- AFX2 Bifurcated Endograft System (Device) $3,004
- GORE CARDIOFORM Septal Occluder (Device) $1,392
- TurboHawk (Device) $597.89
- ENTRESTO (Drug) $256.55
- LEQVIO (Drug) $255.37
- XARELTO (Drug) $242.04
- CoreValve Evolut (Device) $191.09
- ELIQUIS (Drug) $176.76
- Repatha (Biological) $174.28
- Impella (Device) $168.86
- VERQUVO (Drug) $168.50
- CARDIOMEMS (Device) $158.85
- IN.PACT Admiral (Device) $147.97
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $146.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Birmingham
Dr. Anil Rajendra, M.d, M.D
Cardiovascular Disease — Payments: $457,890
Cardiovascular Disease $457,890
Robert Bourge, Md, MD
Cardiovascular Disease — Payments: $433,960
Cardiovascular Disease $433,960
Vikram Arora, Md, MD
Cardiovascular Disease — Payments: $299,075
Cardiovascular Disease $299,075
Dr. William Maddox, M.d, M.D
Cardiovascular Disease — Payments: $172,753
Cardiovascular Disease $172,753
Dr. Gustavo Morales, Md, MD
Cardiovascular Disease — Payments: $124,880
Cardiovascular Disease $124,880
Thomas Cawthon, M.d, M.D
Cardiovascular Disease — Payments: $105,922
Cardiovascular Disease $105,922